← Back to Search

Treatment group for Ileal Conduit

Phase < 1
Waitlist Available
Led By Hamed Ahmadi
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Presence of muscle invasive bladder cancer and planning to undergo radical cystectomy with either ileal conduit or neobladder diversion
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 and 90 days
Awards & highlights

Study Summary

This trial is testing whether it is necessary to give patients with bladder cancer antibiotics before surgery. They want to see if not giving antibiotics is just as effective in preventing infections after surgery as giving a specific antibiotic

Who is the study for?
This trial is for individuals with muscle invasive bladder cancer who are undergoing radical cystectomy and urinary diversion. Specific eligibility details aren't provided, but typically participants must meet certain health criteria to join.Check my eligibility
What is being tested?
The study compares the effect of not using prophylactic antibiotics to taking a specific antibiotic (nitrofurantoin) after surgery, by looking at urinary tract infection rates within 90 days post-operation.See study design
What are the potential side effects?
While specific side effects are not listed for this trial, nitrofurantoin may commonly cause stomach upset or diarrhea and rarely can lead to lung or liver problems.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have bladder cancer and will have surgery to remove my bladder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 and 90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in risk
test for non-inferiority

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment groupExperimental Treatment1 Intervention
Prophylactic antibiotics postoperatively.
Group II: Control groupActive Control1 Intervention
No prophylactic antibiotics post operatively. Participants will receive antibiotics only if needed post-operatively such as for infection

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,382 Previous Clinical Trials
1,551,189 Total Patients Enrolled
Hamed AhmadiPrincipal InvestigatorUniversity of Minnesota

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment of participants currently ongoing for this clinical trial?

"As per the information available on clinicaltrials.gov, this particular clinical trial is currently not actively seeking participants. It was initially posted on January 2nd, 2024 and last updated on the same day. However, it's worth mentioning that there are presently 312 other ongoing clinical trials actively recruiting patients."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Prophylactic Antibiotics in Cystectomy With Diversion
2024. "Prophylactic Antibiotics in Cystectomy With Diversion". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06190197.
~80 spots leftby Oct 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top